Advertisement

Einsatz von tumorbiologischen und molekulargenetischen Methoden?

  • P. Hermanek
Conference paper

Zusammenfassung

Ganz allgemein wäre das Traumziel der klinischen Onkologie, unter möglichen Therapieverfahren durch eine präoperative Biopsie eine zuverlässige Wahl treffen zu können. Daß dies beim Rektumkarzinom für die Entscheidung zwischen lokalen Therapieverfahren und radikaler Resektion nach dem heutigen Wissensstand nicht möglich ist, wurde vorangehend dargestellt (s. Beitrag Hermanek, S. 17 ff.).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Ahlquist DA, Thibodeao SN (1992) Will molecular genetic markers help predict the clinical behaviour of colorectal neoplasia? Gastroenterology 102:1419–1430PubMedGoogle Scholar
  2. 2.
    Bardi G, Johansson B, Pandis N, Bak-Jensen E, Orndal C, Heim S, Mandahl N, An-dren-Sandberg A, Mittelman F (1993) Cytogenetic aberrations in colorectal adenocarcinomas and their correlation with clinico-pathologic features. Cancer 71:306–314PubMedCrossRefGoogle Scholar
  3. 3.
    Baretton G, Gille J, Oevermann E, Loehrs U (1991) Flow cytometric analysis of the DNA-content in paraffin-embedded tissue from colorectal carcinomas and its prognostic significance. Virchow Arch B 60:123–131CrossRefGoogle Scholar
  4. 4.
    Dean DA, Vernava AM III (1992) Flow cytometric analysis of DNA content in colorectal carcinoma. Dis Colon Rectum 35:95–102PubMedCrossRefGoogle Scholar
  5. 5.
    Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767PubMedCrossRefGoogle Scholar
  6. 6.
    Finkelstein SD, Sayegh R, Christensen S, Swalsky PA (1993) Genotypic classification of colorectal adenocarcinoma. Biologic behaviour correlates with K-ras-2 mutation type. Cancer 71:3827–3838PubMedCrossRefGoogle Scholar
  7. 7.
    Hamilton SR (1992) Molecular genetic alterations as potential prognostic indicators in colorectal carcinoma. Cancer 69:1589–1591PubMedCrossRefGoogle Scholar
  8. 8.
    Hermanek P (1992) Dysplasie-Karzinom-Sequenz im Kolorektum. Zentralbl Chir 117:476–482PubMedGoogle Scholar
  9. 9.
    Kearney TJ, Price EA, Lee S, Silberman AW (1993) Tumor aneuploidy in young patients with colorectal cancer. Cancer 72:42–45PubMedCrossRefGoogle Scholar
  10. 10.
    Kimura O, Kijima T, Moriwaki S, Hoshino K, Yonekawa M, Sugezawa A, Kaibara N (1992) DNA index as a significant indicator of lymph node metastasis and local recurrence of rectal cancer. Dis Colon Rectum 35:1130–1134PubMedCrossRefGoogle Scholar
  11. 11.
    Kubota Y, Petras RE, Easley KA, Bauer TW, Tubbs RR, Fazio VW (1992) Ki-67 determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. A multivariate analysis. Cancer 70:2602–2609PubMedCrossRefGoogle Scholar
  12. 12.
    Mayer A, Takimoto M, Fritz E, Schellander G, Kofler K, Ludwig H (1993) The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer 71:2454–2460PubMedCrossRefGoogle Scholar
  13. 13.
    Rüschoff J, Bittinger A, Neumann K, Schmitz-Moormann P (1990) Prognostic significance of nuclear organizing regions (NORs) in carcinomas of the sigmoid colon and rectum. Pathol Res Pract 186:85–91PubMedGoogle Scholar
  14. 14.
    Solomon E (1990) Colorectal cancer gens. Nature 343:412–414PubMedCrossRefGoogle Scholar
  15. 15.
    Streffer C, van Beuningen D, Gross E (1986) Predictive assays for the therapy of rectal cancer. Radiother Oncol 5:303–310PubMedCrossRefGoogle Scholar
  16. 16.
    Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM, Bos JL (1988) Genetic alterations during colorectal tumor development. N Engl J Med 319:525–532PubMedCrossRefGoogle Scholar
  17. 17.
    Vogelstein B, Fearon ER, Kern SE, Hamilton SR, Preisinger AC, Nakamura Y, White R (1989) Allelotype of colorectal carcinoma. Science 244:209–211CrossRefGoogle Scholar
  18. 18.
    Vogelstein B, Kinzler KW (1992) p53 function and dysfunction. Cell 70:523–526PubMedCrossRefGoogle Scholar
  19. 19.
    Wahlstrom B, Branchog I, Stierner U, Sunzel H, Hohnberg E (1992) Association of ploidy and cell proliferation, Dukes’ classification, and histopathological differentiation in adenocarcinomas of colon and rectum. Eur J Surg 158:237–243PubMedGoogle Scholar
  20. 20.
    Yamaguchi A, Kurosaka Y, Fushida S, Kanno M, Yonemura Y, Miwa K, Miyazaki I (1992) Expression of p53 protein in colorectal cancer and its relationship to short-term prognosis. Cancer 70:2778–2784PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • P. Hermanek

There are no affiliations available

Personalised recommendations